Swisher Daniel N JR sold $111K of CORT
Swisher Daniel N JR sold 1,500 shares of CORCEPT THERAPEUTICS INC (CORT) at $74.07 ($0.11M total) on 2026-11-10 under a Rule 10b5-1 trading plan.
How this was made
The 30-second read
Why it matters
A director's complete exit may be interpreted as a lack of confidence, potentially prompting short sellers.
Market read
The filing provides new, material information about insider ownership, but the monetary size is modest, limiting broader market impact.
What to watch
The director may have needed liquidity; the sale price was close to market.
Background
SEC Form 4 filings disclose insider transactions; they are primary sources for such events.
Ticker impact
Director Swisher Daniel N Jr sold 1,500 shares for $111,105 via a 10b5-1 plan, reducing his holding to zero.
likely modest downside as market prices in the insider sell
A director offloading a sizable position, even at a modest $111K, often prompts short-term selling pressure.
Market effects
Minimal impact on the biotech sector; insider sales are company‑specific.
None
None
Counterpoint
The sale could be routine portfolio rebalancing, not a negative signal.
Key entities
- CompanyCorcept Therapeutics Inc.
Biopharma company listed on NASDAQ under ticker CORT.
- IndividualSwisher Daniel N Jr
Director of Corcept Therapeutics who sold his shares.


